What is Invaio Sciences?
Invaio Sciences operates at the intersection of human therapeutics, environmental science, and advanced manufacturing. Founded in 2018 by Flagship Pioneering, the company utilizes a proprietary technology platform to decode the physiology of insects, plants, and trees. By developing integrated solutions that are both effective against pests and mindful of beneficial organisms, Invaio is carving out a leadership position in the sustainable agriculture sector. Their market position is defined by a commitment to precision agriculture, aiming to replace traditional, broad-spectrum chemical applications with targeted, science-backed interventions that improve yield and environmental safety.
How much funding has Invaio Sciences raised?
Invaio Sciences has raised a total of $138.9M across 2 funding rounds:
Series C
$88.9M
Debt
$50M
Series C (2021): $88.9M with participation from Stage 1 Ventures, Bluwave Capital, and Alexandria Venture Investments
Debt (2021): $50M led by K2 HealthVentures
Key Investors in Invaio Sciences
K2 HealthVentures
K2 HealthVentures is an alternative investment firm providing flexible, long-term financing solutions to innovative companies within the life sciences and healthcare sectors.
Stage 1 Ventures
Stage 1 Ventures is a venture capital firm focused on early-stage companies that are transforming global industries through disruptive deep tech and scientific innovation.
Alexandria Venture Investments
Alexandria Venture Investments is the strategic venture capital arm of Alexandria Real Estate Equities, focusing on innovative life science and agtech companies.
What's next for Invaio Sciences?
With the recent capital infusion, Invaio Sciences is expected to scale its commercial operations and expand its global footprint. The strategic focus will likely shift toward the commercialization of its novel delivery systems and the expansion of its intellectual property portfolio. As the company transitions from a research-heavy development phase to a market-scaling enterprise, the focus will remain on proving the efficacy of its solutions across diverse agricultural landscapes. Investors are closely watching how the firm leverages this financing to disrupt the multi-billion dollar pesticide industry, potentially setting a new standard for ecological stewardship in commercial farming.
See full Invaio Sciences company page
